Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core
Matos MJ., Vilar S., Kachler S., Vazquez-Rodriguez S., Varela C., Delogu G., Hripcsak G., Santana L., Uriarte E., Klotz K-N., Borges F.
<p>3-Thiophenylcoumarins are described as adenosine receptor ligands. Synthesis, <italic>in vitro</italic> pharmacological assays and docking studies were performed.</p>